Abstract: Decellularized whole organs represent ideal scaffolds for engineering new organs and/or cell transplantation. Here, we investigate whether decellularized liver scaffolds provide cell-friendly biocompatible three-dimensional (3-D) environment to support the proliferation and differentiation of hepatic progenitor cells. Mouse liver tissues are efficiently decellularized through portal vein perfusion. Using the reversibly immortalized mouse fetal hepatic progenitor cells (iHPCs), we are able to effectively recellularize the decellularized liver scaffolds. The perfused iHPCs survive and proliferate in the 3-D scaffolds in vitro for 2 weeks. When the recellularized scaffolds are implanted into the kidney capsule of athymic nude mice, cell survival and proliferation of the implanted scaffolds are readily detected by whole body imaging for 10 days. Furthermore, epidermal growth factor (EGF) is shown to significantly promote the proliferation and differentiation of the implanted iHPCs. Histologic and immunochemical analyzes indicate that iHPCs are able to proliferate and differentiate to mature hepatocytes upon EGF stimulation in the scaffolds. The recellularization of the biomaterial scaffolds is accompanied with vascularization. Taken together, these results indicate that decullarized liver scaffolds effectively support the proliferation and differentiation of iHPCs, suggesting that decellularized liver matrix may be used as ideal biocompatible scaffolds for hepatocyte transplantation. 
INTRODUCTION
Successful organ transplantation is the ultimate treatment for end-stage organ failure. [1] [2] [3] [4] [5] [6] [7] However, the demand for suitable organs for transplantation far exceeds the available donor organs. Thus, there is an urgent need to develop solid organs for transplantation using tissue engineering and regenerative medicine-based strategies. The ultimate goal of tissue engineering is to reconstruct tissues or organs in order to physically and/or functionally replace damaged and injured organs. A successful tissue engineering endeavor consists of at least three essential components, including tissue-specific cells, scaffolding biomaterials and an appropriate environment for promoting tissue formation. [2] [3] [4] [5] [6] [7] Significant advances have been made in the development of engineered tissues, such as blood vessels, urinary bladder and trachea. [2] [3] [4] [5] [6] [7] However, whole organ construction for large organs, such as the heart, lung, liver, and kidney, requires immediate access to the blood supply after transplantation, which requires extensive vascular networks for nutrient and gas exchange in order to obtain nutrients and oxygen. 1 Whole organ decellularization represents an ideal choice for the fabrication of scaffolds for engineering new organs because the scaffolds should consist of naturally derived *Recipient of the predoctorate fellowship from the China Scholarship Council. Correspondence to: T.-C. He; e-mail: tche@uchicago.edu and J. Dong; e-mail: dongjh301@163.com Contract grant sponsor: National Institutes of Health (to TCH, RCH, and HHL) Contract grant sponsor: Natural Science Foundation of China (NSFC); contract grant numbers: #81100309 (to YB) and #30972586 and #31171307 (to NT) Contract grant sponsor: Key National S & T Program; contract grant numbers: #2013ZX10002002-005-003 and #2012ZX10002005-003-002 (to NT) extracellular matrix (ECM) and thus maintain tissue microarchitecture, including intact vascular networks ready to integrate into the recipient's circulatory system. A significant advancement in the field of bioscaffold design is the utilization of decellularized tissue as the three-dimensional (3-D) scaffold in tissue engineering strategies. The decellularized tissues, which have no intact cells and nuclei but remain collagen, elastic fibers and intact ECM network, have been proved as an effective barrier to penetration of the scaffold by seeded cells. [8] [9] [10] [11] The seeded cells can be mature cells or fetal cells. 12 The ECM consists of a complex mixture of functional and structural molecules, which are usually arranged in a unique, tissue-specific, 3-D ultrastructure and are ideally suited to the tissue or organ from which the ECM is harvested. Because the ECM is produced by the resident cell populations, it is logical that the specific composition and ultrastructural organization of the component molecules will vary depending on the source tissue/organ from which the ECM scaffold is prepared. Accordingly, the potential importance of organ specificity with regard to the source of ECM may be considered as a template for organ restoration. For example, ECM harvested from liver tissue may be the preferred ECM substrate for hepatocytes.
1,2
Hepatocyte transplantation has been considered as an attractive alternative to liver transplantation for a variety of liver diseases. 2 Clinical application of hepatocyte transplantation has been limited by good quality donor livers for the isolation of cells. Although the recently discovered technologies for reprogramming of postnatal cells into pluripotent stem cells may offer a promising approach toward the generation of patient-specific autologous cells, many issues regarding the safety and efficacy need to be answered before these cells can be applied in clinical trials.
In this study, we investigate whether the decellularized liver matrix scaffolds can efficiently support the survival and proliferation of hepatic progenitor cells both in vitro and in vivo. We demonstrate that mouse liver tissues are efficiently decellularized through a simplified portal vein perfusion procedure. Using the reversibly immortalized mouse fetal hepatic progenitor cells (iHPCs), we are able to effectively recellularize the decellularized liver scaffolds. The perfused iHPCs can survive and proliferate in the 3-D scaffolds in vitro for up to 2 weeks. When the recellularized scaffolds are implanted into the kidney capsule of athymic nude mice, the cell survival, and proliferation of the implanted scaffolds are readily detected by whole body imaging for up to 10 days. Furthermore, epidermal growth factor (EGF) is shown to significantly promote the survival and proliferation of the implanted iHPCs. The histologic and immunochemical analyses indicate that the iHPCs are able to proliferate and differentiate to mature hepatocytes upon EGF stimulation in the scaffolds. Interestingly, the recellularization of the biomaterial scaffolds was accompanied with vascularization within the scaffolds. Thus, these results demonstrate that decullarized liver scaffolds may effectively support the proliferation and differentiation of iHPCs, suggesting that the decellularized matrix may be ideal scaffolds for hepatocyte transplantation.
MATERIALS AND METHODS
Cell culture and chemicals HEK-293 cells were purchased from ATCC (Manassas, VA) and were maintained in complete Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum (FBS, Invitrogen), 100 units/mL of penicillin and 100 lg/mL of streptomycin at 37 C in 5% CO 2 . 13, 14 The retinoic acids were purchased from Enzo Life Sciences (NY) and dissolved in dimethyl sulfoxide (DMSO). Recombinant human EGF (rhEGF) was purchased from Sigma-Aldrich (St. Louis, MO). Unless indicated otherwise, all chemicals were purchased Fisher Scientific (Pittsburgh, PA).
Construction and generation of recombinant adenoviruses expressing EGF, b-catenin, or green fluorescent protein Recombinant adenoviruses were generated using the AdEasy technology as described. [15] [16] [17] [18] [19] The coding regions of human EGF and human oncogenic mutant b-catenin were polymerase chain reaction (PCR) amplified and cloned into an adenoviral shuttle vector, and subsequently used to generate recombinant adenoviruses in HEK-293 cells. The resulting adenoviruses were designated as Ad-EGF or Adbcatenin, both of which also express green fluorescent protein (GFP). Analogous adenovirus expressing only GFP (AdGFP) was used as controls. 14, 16, [19] [20] [21] [22] Isolation and iHPCs All animal experiments were performed by following the NIH guidelines approved by the Institutional Animal Care and Use Committee. E13.5-E14.5 embryos were obtained from timed pregnancy of CD1 female mice (Harlan Laboratories, IN). The fetal liver cells were isolated as described previously. [23] [24] [25] Briefly, the fetal liver tissues were dissected, rinsed with sterile ice-cold PBS, minced into small pieces, and incubated in 0.25% trypsin/1 mM ethylenediaminetetraacetic acid with gentle agitations at 37 C for 15 min. The digestion was terminated by adding 10% FBS DMEM. Cell debris/undigested tissue bits were removed by passing the mix through 100 mm cell filter strainers. Cells were seeded onto 100 mm cell culture dishes precoated with type I collagen, and incubated at 37 C and 5% CO 2 . Nonadherent cells were removed at 24 h. Once reaching approximately 90% confluence, cell were passaged for making immortalized cells.
For making iHPCs, a retroviral vector SSR #69 expressing SV40 large T antigen flanked with loxP sites was used. 23, 24, [26] [27] [28] Retrovirus expressing SV40 large T antigen was first packaged by cotransfecting SSR #69 and the packaging vector pCLAmpho into HEK-293 cells. The filtered viral supernatants were used to infect the primary fetal hepatocytes. The stable and immortalized cells, designated as iHPCs, were selected in the presence of 0.3 mg/mL hygromycin B (Invitrogen) for 7-10 days, as reported previously.
23-25,27,28
Construction of albumin promoter-driven Gaussia luciferase (Alb-GLuc) reporter and reporter assays A 2.5-kb genomic DNA fragment containing the mouse albumin (Alb) gene promoter was PCR amplified and subcloned into a homemade pSEB-GLuc retroviral vector to drive expression of Gaussia luciferase (pSEB-Alb-GLuc) as described. 23, 24 The constructed reporter was used for transient reporter assays. Authenticity of the PCR amplified fragments was verified by DNA sequencing.
For reporter assays, subconfluent iHPCs were first transfected in 25 cm2 flasks with pSEB-Alb-GLuc using Lipofect-AMINE (Invitrogen). At 16h post-transfection, cells were replated to 24-well plates and stimulated with rhEGF (0, 0.1, or 0.5 ng), infected with AdGFP and Adb-catenin, or treated with DMSO, 9-cis retinoic acid (RA, 0.5 lM) or dexamethasone (Dex, 0.1 lM). Culture media were collected for Gaussia luciferase assays at day 3 (for Dex, RA and b-catenin) or days 1 and 4 (for rhEGF), using the Gaussia Luciferase Assay Kit (New England Biolabs). All assay conditions were performed in triplicate. Reporter activity was expressed as mean 6 standard deviation.
Generation of decellularized liver scaffolds
Male balb/c mice (25-30 g; Jackson Laboratory) were used for liver procurement. Briefly, the animals were first anesthetized with by intraperitoneal (i.p.) injections of ketamine and xylazine. The incision was made in the upper abdomen to expose the liver. A 24-gauge catheter (Terumo Medical Corporation, Elkton, MD) was cannulated into the portal vein. Blood clotting was prevented by slowly injecting 50 mL of sterile PBS (containing 12.5 U/mL heparin) into portal vein through the catheter while leaving the inferior vena cava open as an outlet flow. The perfused liver was then removed from the animal and rinsed with PBS containing 100 units/mL penicillin and 100 lg/mL streptomycin. The excised liver tissues were transferred to 100 mm cell culture dishes and perfused for 2 h with 1% sodium dodecyl sulfate (SDS) solution, followed by 30 min perfusion with 1% Triton-X 100, both at room temperature with a perfusion rate of 5 mL/min. The decellularized liver scaffolds were perfused and washed with sterile PBS to remove any residual detergents for 3 h.
Assessment of decellularization using DNA content analysis
The decellularized liver samples (approximately 25-30 mg) and control liver samples were minced into small pieces and digested with alkaline lysis buffer at 85 C for 20 min or until no visible materials remained. The digested mixtures were subjected to phenol-chloroform extractions and ethanol precipitation. The DNA concentrations were determined by using the PicoGreen DNA assay kit (Invitrogen). Total DNA content for each sample (ng/mg tissue) was calculated.
Recellularization of the liver scaffolds for in vitro 3-D culture The decullarized liver scaffolds were thoroughly perfused with sterile PBS to remove any residual detergents and chemicals. The scaffolds were then placed in 100 mm cell culture dishes and perfused with 5 mL of the completed DMEM (containing 10% FBS) through the catheter connected with the portal vein. Subconfluent iHPCs were infected with AdGFP for 24 h, collected, and perfused into the decullarized liver scaffolds (10 e7 cells/scaffold). The recellularized scaffolds were cultured in 5% CO 2 at 37 C for up to 14 days.
Renal capsule grafting assay of iHPCs in a mouse model Male athymic nude mice (25-30 g, Harlan Laboratories, IN) were used as transplant recipients. Subconfluent iHPC cells tagged with firefly luciferase (iHPC-FLuc) were transduced with AdGFP or Ad-EGF for 24 h, collected, and perfused into the decullarized liver scaffolds (10 e7 cells/scaffold). The recellularized scaffolds were cultured for another 24 h to let the cells adhere, then gently cut into 0.5 cm 3 pieces, and implanted into the left kidney capsule of athymic nude mice. Scaffolds without recellularization were also performed as negative controls. The animals were not restricted to any activities for up to 10 days.
Xenogen bioluminescence imaging analysis
Bioluminescence imaging was performed at the indicated time points. Briefly, mice were anesthetized with isoflurane attached to a nosecone mask within Xenogen IVIS 200 imaging system as described. 13, [29] [30] [31] [32] [33] Mice were injected (i.p.)
with D-Luciferin sodium salt (Gold BioTechnology) at 100 mg/kg in 0.1 mL PBS. The pseudoimages were obtained by superimposing the emitted light over the gray-scale photographs of the mice. Quantitative analysis was done with Xenogen's Living Image software.
Histologic evaluation, trichrome staining, and immunohistochemical staining The scaffolds from in vitro or in vivo studies were first fixed in 10% formalin and subjected to frozen sectioning. Sections were routinely stained with hematoxylin and eosin (H&E).
Trichrome staining was performed on the decellullarized liver scaffolds as described. 18, 28, [34] [35] [36] [37] Anti-GFP immunohistochemical staining (Clontech) was performed to reaffirm the recellularization. Immunohistochemical staining was also performed using anti-mouse albumin (Alb, Santa Cruz) and anti-CD31 (Abcam, MA) were also performed as described previously. 29, 31, 38, 39 Statistical analysis The Prism 5 software and Microsoft Excel were used for statistical analysis. Differences between samples were analyzed by using the two-tailed Student t test. A p-value <0.05 was considered statistically significant.
RESULTS
Decellularized tissue scaffolds can be efficiently prepared from mouse livers using a simplified perfusion protocol In order to prepare decellularized liver scaffolds, we used young adult male balb/c mice. While the animals were under anesthesia, mouse livers were exposed and perfused with anticoagulation heparin-containing PBS through the portal vein [ Fig. 1(A), panels a antibiotics-containing PBS [ Fig. 1(A) , panel c], followed by perfusion with 1% Triton-X 100. The decellularized liver scaffolds were perfused and washed with sterile PBS to remove any residual detergents [ Fig. 1(A), panel d] . The complete protocol for decellularization usually lasted about 4 h.
The quality of the decellularized liver scaffolds was first examined by H&E staining. Compared with the unprocessed liver tissues [ Fig. 1(B) , panel a], decellularized liver tissues have no identifiable cells [ Fig. 1(B), panel b] , indicating the decellularization was efficient and thorough. The decellularization was further confirmed by using Masson's trichrome staining. Compared with the control liver tissues [ Fig. 1 (C), panel a], the red-staining cytoplasm almost completely disappeared in the decellularized liver scaffolds [ Fig. 1(C),  panel b] . Furthermore, we determined the total DNA contents in the control livers and the decellularized scaffolds and found that the total DNA content for the decellularized liver scaffolds was about 0.6% of that for the control unprocessed liver tissues [ Fig. 1(D) ]. Thus, taking these results together we have demonstrated that our decellularization protocol is efficient to remove the cellular components from mouse liver tissues.
The decellularized liver scaffolds are efficiently recellularized with the iHPCs in 3-D culture in vitro To test if the decellularized scaffolds can support the proliferation and growth of hepatocytes, we first sought to isolate and establish the iHPCs from mouse E13.5-E14.5 embryos. The fetal liver cells were isolated as described previously. [23] [24] [25] For making iHPCs, the retroviral vector SSR #69 expressing SV40 large T antigen flanked with loxP sites [ Fig. 2(A) ] was used. 23, 24, [26] [27] [28] The stable and immortalized iHPCs were selected in the presence of hygromycin B, as described previously. [23] [24] [25] 27, 28 When seeded at the same density, the immortalized cells grew at a much faster rate than that of the primary cell's [ Fig. 2(B) ].
We further analyze the differentiation potential of iHPCs using the liver-specific albumin-driven Gaussia luciferase reporter (Alb-GLuc) as described previously [23] [24] [25] [ Fig. 2(C) ]. Consistent with our previously reported findings, 23 Dex and retinoic acid were shown to induce Alb-GLuc activity [ Fig. 2(D), panel a] . When the iHPCs were transduced with adenovirus expressing the oncogenic mutant form of human b-catenin, Alb-GLuc activity was significantly induced [ Fig. 2(D) , panel a], consistent with our previously reported important roles of Wnt signaling in hepatic differentiation. 24 Furthermore, the rhEGF was also shown to effectively induce Alb-GLuc activity [ Fig. 2(D), panel b] . These results indicate that the iHPCs have long-term proliferative activity and can differentiate hepatocyte-like cells when stimulated with proper differentiation cues.
Using the iHPCs, we sought to test whether hepatic progenitor cells would survive and propagate in the 3-D culture using the decellularized liver scaffolds. The iHPCs were first transduced with AdGFP and then perfused into the decellularized liver scaffolds through the portal vein. We found that the scaffolds were easily recellularized with the GFP-labeled iHPCs [ Fig. 3(A) ]. In fact, the transduced iHPCs were able to survive and proliferate for up to 2 weeks in the 3-D culture [ Fig. 3(A) , panels a and d vs. b, c, e, and f]. H&E staining of the in vitro cultured scaffolds confirms that the perfused iHPCs survived and proliferated in the decellularized liver scaffolds. Thus, these in vitro findings suggest that the scaffolds may provide a suitable environment for iHPCs' survival and proliferation.
The decellularized liver scaffolds provide biocompatible 3-D environment to support the proliferation and differentiation of iHPCs in a mouse renal capsule grafting model We further tested the in vivo properties of the decellularized liver scaffolds in a mouse renal capsule implantation model. Subconfluent firefly luciferase-tagged iHPCs were first transduced with Ad-EGF or control AdGFP for 24 h [Fig. 4(A) ], collected, and perfused into the decellularized liver scaffolds. The recellularized scaffolds were cultured for another 24 h and then gently cut into small pieces, and implanted into the left kidney capsule of athymic nude mice [ Fig. 4(B) ]. Scaffolds without recellularization were also performed as a negative control. The cell survival and proliferation of the implanted scaffolds was readily monitored by whole body imaging. While the iHPCs were shown to survive in the implants for up to 10 days, EGF significantly promoted the survival and proliferation of the implanted iHPCs when compared with the GFP controls [ Fig. 4(C) ]. Nonetheless, there was a time point-dependent decrease in the signal intensities of Xenogen bioluminescence imaging analysis in EGF-stimulated iHPCs [ Fig. 4(D) ]. The decreased signal intensity may indicate that the iHPCs reached the maximum proliferation capacity in the scaffold environment or the iHPCs and/or the iHPCs were undergoing differentiation/ maturation.
When the recellularized liver scaffold implants were retrieved and subjected to histologic and immunochemical analyses, we found that the iHPCs were able to proliferate in the scaffolds as indicated by the H&E staining [ Fig. 5(A) ]. Immunohistochemical staining using anti-GFP antibody indicated that most of the implanted iHPCs were transduced by adenoviral vectors [ Fig. 5(B) ]. We further examined the 26-28 B, Growth and morphological features of the primary (a) and the immortalized HPCs (iHPCs; b). The immortalization was carried out as described. 23, 24 The cells were seeded at the same density and were photographed at day 4 after plating. Representative images are shown. C, Construction of an albumin promoter-driven Gaussia luciferease reporter (Alb-GLuc). A 2.5-kb fragment containing the mouse albumin promoter region was cloned in front of Gaussia luciferase, resulting in the Alb-GLuc reporter, which was used to make stable Alb-GLuc reporter lines. D, The Alb-GLuc reporter is used to monitor the differentiation status of the iHPCs. Several known hepatic differentiation factors, including b-catenin, dexamethasone, and retinoic acid (a) and rhEGF (b), were shown to induce Alb-GLuc activities. *, p-value <0.05 and **, p-value <0.001. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary. 
DISCUSSION
Organ transplantation has been hampered by limited availabilities of quality organs. In the United States, it is estimated about 27,000 deaths annually are caused by liver diseases. Liver transplantation is the established treatment for individuals with acute liver failure, end-stage liver disease, or inherited liver-based metabolic disorders. Furthermore, the complexity liver functions make it impossible to use simple mechanical devices to provide temporary support. The scarcity of donor livers leads to too many patients on the waiting list, many of whom may never undergo liver transplantation. While orthotopic transplantation remains as an optimal option, the increasing donor organ shortage requires consideration of alternative emerging technologies. 2 One such technology is to use cell transplantation. [1] [2] [3] [4] 40 Here, we investigate if the decellularized liver matrix scaffolds can efficiently support the survival and proliferation of hepatic progenitor cells. Using a simplified portal vein perfusion procedure, we can effectively decellularize the mouse liver tissues, as assed by histologic examination and total DNA content determination. We further establish and characterize the reversibly iHPCs derived from mouse E13.5-E14.5 embryos. Through port vein perfusion, we are able to effectively recellularize the decellularized liver scaffolds. The perfused iHPCs can survive and proliferate in the 3-D scaffolds in vitro, as well as in a kidney capsule implantation model of athymic nude mice. Differentiation promoting factor EGF is shown to significantly promote the survival and differentiation of the implanted iHPCs. The recellularization of the biomaterial scaffolds is also accompanied with vascularization within the scaffolds. Thus, our results demonstrate that decullarized liver scaffolds may be ideal scaffolds for hepatocyte transplantation.
Numerous methods can be used to decellularize biologic organs, including physical, enzymatic and chemical. [1] [2] [3] [4] [5] [6] [7] In most cases, the detergent SDS followed by Triton X-100 is proven as an efficient method, which is also confirmed in our case. We have demonstrated that the decellularization can be effectively achieved acellular matrix within several hours. The whole procedure can be performed at room temperature, although the sterility is required for the entire procedure.
Although embryonic stem cells or induced pluripotent stem cells may serve a good resource for stem cell-based transplantation and therapies, their availability and potentially hazardous biosafety profiles may hamper their eventual applications in clinical settings. In this study, we have established and characterized the reversibly immortalized hepatic progenitor cells from mouse fetal liver using a retroviral vector expressing SV40 large T antigen flanked with Cre/loxP sites. 26 We have demonstrated that the immortalization process is reversible (data now shown). More importantly, the immortalized hepatic progenitor cells retain the differentiation potential upon proper differentiation stimuli, such as Wnt signaling, Dex, retinoic acids, or EGF. Thus, the iHPCs may be used as an important tool to investigate liver cell transplantation, as well as the basic research about molecular mechanisms behind hepatocyte proliferation and differentiation. Taken together, our results have demonstrated that the decellularized liver matrix can be used as cellfriendly biomaterial scaffolds for hepatic progenitor cell transplantation.
CONCLUSIONS
The objective of this study was to evaluate whether the decellularized liver scaffolds can efficiently support the survival and proliferation of hepatic progenitor cells. We have shown that mouse liver tissues can be efficiently decellularized through a simplified portal vein perfusion procedure. We establish and characterize the reversibly iHPCs and are able to effectively recellularize the decellularized liver scaffolds. The perfused iHPCs can survive and proliferate in the e7 iHPC-FLuc cells were transduced with AdGFP or Ad-EGF for 16 h, collected, and perfused into the decellularized liver scaffolds. Small pieces of the cell-loaded scaffolds were implanted into the left renal capsules of athymic nude mice (indicated by an arrow; n 5 5 per group). A representative image is shown. C and D, Monitoring the EGF-promoted cell proliferation in renal capsule using xenogen bioluminescence imaging analysis. At the indicated time points post rafting, the animals were subjected to the Xenogen IVIS 200 Imaging System (C). The average signal intensities were quantitatively calculated using Xenogen's Living Image software (D), as described previously. 13, 29, 33 ** indicates that p-values were <0.01 when the average signals of the EGF-treated groups were compared with that of the GFP control groups'. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
3-D scaffolds in vitro and in the kidney capsule implantation model of athymic nude mice. EGF is shown to significantly promote the survival and proliferation of the implanted iHPCs in vivo. The histologic and immunochemical analyses indicate that the iHPCs are able to proliferate and differentiate to mature hepatocytes upon EGF stimulation in the scaffolds. Therefore, our results demonstrate that decullarized liver scaffolds may effectively support the proliferation and differentiation of iHPCs, suggesting that the decellularized matrix may be used as ideal biocompatible scaffolds for hepatocyte transplantation.
